Skip to main content
Log in

Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in pregnancy and at delivery

  • Originals
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Summary

Using conventional radioimmunoassay kits, we measured concentrations of two cancer-related antigens, tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) throughout gestation and at delivery. The maternal serum was collected from 147 pregnant women between 5 and 43 weeks gestation and 27 women were studied at delivery at which time samples of maternal blood, umbilical artery and vein blood as well as amniotic fluid were collected. The various concentrations of TPA and CA125 were compared with placental weight and infant birth weight. The results are summarized as follows:

  1. (1)

    Mean TPA levels in maternal serum increased with advancing gestation and rose above 110 U/l (upper non-pregnant limit) from 35 weeks onwards. Mean CA125 levels rose above 35 U/ml (normal non-pregnant upper limit) before 9 weeks gestation and thereafter fell. Both levels were markedly raised immediately after delivery.

  2. (2)

    In umbilical artery and vein serum, mean TPA levels were slightly raised. However, there were no significant differences between TPA levels in maternal serum and matched serum from the umbilical artery and vein. Mean umbilical CA125 levels were below 35 U/ml, while mean CA125 levels were significantly higher in the corresponding maternal serum.

  3. (3)

    The concentrations of TPA and CA125 were extremely high in amniotic fluid. The mean values reached 3604 U/l and 2187 U/ml, respectively.

  4. (4)

    None of the concentrations of TPA and CA125 in those pregnancy-related body fluids correlated significantly with birth weight, placental weight or fetal sex.

These findings suggest that the production of these two cancer-related antigens is not by the fetus but the placenta.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bast RC, Feeney M jr, Lazarus H, Nadler LM (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin Invest 68:1331–1337

    Google Scholar 

  2. Bast RC, Klug, TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths T, Parker L, Zurawski, VR, Knapp RC (1983) A radioimmunoassay using monoclonal antibody to monitor the course of epithelial ovarian cancer. New Engl J Med 309:883–887

    Google Scholar 

  3. Björklund B (1981) Tissue polypeptide antigen, review and recent progress. Contr Oncol 7:73–87

    Google Scholar 

  4. Björglund B, Björklund V (1957) Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique: presence of an insoluble, heat-labile tumor antigen. Int Arch Allergy 10:153–184

    Google Scholar 

  5. Björklund B, Wiklund B, Lüning B, Anderson K, Kallin E, Björklund V (1980) Radioimmuno-assay of TPA. A laboratory test in cancer. Tumor Diagnostik 1:78–84

    Google Scholar 

  6. Braunstein GD, Rasor J, Adler S, Vaitukaitis JL, Ross GT (1973) Serum human chorionic gonadotropin levels throughout normal pregnancy. Am J Obstet Gynecol 126:678–681

    Google Scholar 

  7. Bremme K, Eneroth P, Nilsson B, Olsson M (1985) Maternal and cord serum levels of tissue polypeptide antigen (TPA) in normal pregnancies. Gynecol Obstet Invest 19:118–123

    Google Scholar 

  8. Eerdekens MW, Nouwen EJ, Pollet DE, Briers TW, De Broe ME (1985) Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases. Clin Chem 31:687–690

    Google Scholar 

  9. Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H, Sato T, Takamizawa H, Wiklund B (1988) Serum levels of six tumor markers in patients with benign and malignant gynecological disease. Arch Gynecol Obstet 243:61–68

    Google Scholar 

  10. Gordon YB, Jeffrey D, Grudzinskas JG, Chard T (1977) Concentrations of pregnancy-specific β1-glycoprotein in maternal blood in normal pregnancy and in intrauterine growth retardation. Lancet 1:331–333

    Google Scholar 

  11. Hagbard K, Sorbe B (1978) Preliminary experiences of TPA (Tissue Polypeptide Antigen) in cancer of the ovary. Lakartidningen 75:3433–3435

    Google Scholar 

  12. Ikarashi T, Takeuchi S (1987) Immunohistochemical localization of placental proteins and tumor-associated antigens in endometrial cancer and endometrial hyperplasia. Acta Obstet Gynaecol Jpn 39:1634–1640

    Google Scholar 

  13. Inaba N, Ijichi M, Fukazawa I, Satoh N, Nito A, Ota Y, Iwasawa H, Sekiya S, Takamizawa H, Okabe M, Kubota N, Wiklund B, Björklund V, Björklund B (1984) Tissue polypetide antigen (TPA) in the field of obstetrics and gynecology. In: Proceedings of 2nd International Conference on Human Tumor Markers (Vienna) No. 207

  14. Inaba N, Fukazawa I, Ota Y, Nito A, Ijichi M, Sato N, Takamizawa H (1985) Tissue polypeptide antigen and cancer antigen 125 in pregnancy. — These two cancer-related antigens are oncoplacental? Acta Obstet Gynaecol Jpn 37:2139–2140

    Google Scholar 

  15. Itahashi K, Inaba N, Takamizawa H (1988) Immunohistochemical study of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in the human and cynomolgus monkey placenta, umbilical cord and decidua. Arch Gynecol Obstet 243:145–155

    Google Scholar 

  16. Kabawat SE, Bast RC jr, Bhan AK, Welch WR, Knapp RC, Colvin RB (1983) Tissue distribution of a coelomic epithelium related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol 2:275–285

    Google Scholar 

  17. Kabawat SE, Bast RC jr, Welch WR, Knapp RC, Colvin RB (1983) Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol 79:98–104

    Google Scholar 

  18. Klug TL, Bast RC jr, Niloff JM, Knapp RC, Zurawski VR jr (1984) Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA125) associated with human epithelial ovarian carcinomas. Cancer Res 44:1048–1053

    Google Scholar 

  19. Menendez-Botet CJ, Oettgen HF, Pinsky CM, Schwartz MK (1978) A preliminary evaluation of tissue polypeptide antigen in serum or urine (both) of patients with cancer or benign neoplasms. Clin Chem 24:868–872

    Google Scholar 

  20. Nemoto T, Constantine R, Chu TM (1979) Human tissue polypeptide antigen in breast cancer. J Nat Cancer Inst 63:1347–1350

    Google Scholar 

  21. Stryten A, Unsgaard B, Björklund B, Eklund G (1981) Serum TPA related to activity in a wide spectrum of cancer conditions. Tumor Diagnostik 2:117–120

    Google Scholar 

  22. Szymendera JJ (1986) Clinical usefulness of three monoclonal antibody-defined tumor markers: CA19-9, CA50, and CA125. Tumor Biology 7:333–342

    Google Scholar 

  23. Takamizawa H, Inaba N, Iwasawa H, Fukazawa I, Ijichi M, Sato N, Tsunashima I, Ota Y, Sakamoto M, Nito A (1984) A new tumor marker, cancer antigen 125 in the field of obstetrics and gynecology (in Japanese). Igaku to Yakugaku 12:248–257

    Google Scholar 

  24. Towler CM, Jandial V, Horne CHW, Bohn H (1976) A serial study of pregnancy proteins in primigravidae. Br J Obstet Gynecol 83:368–374

    Google Scholar 

  25. Wiklund B (1980) Studies on tissue polypeptide antigen (TPA) and its antigenic determinant. Chem Commun Univ Stockholm: Dissertation

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Itahashi, K., Inaba, N., Fukazawa, I. et al. Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in pregnancy and at delivery. Arch Gynecol Obstet 243, 191–197 (1988). https://doi.org/10.1007/BF00932267

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00932267

Key words

Navigation